← All trials
NCT07269704
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 15, 2023
- Primary completion
- Jun 10, 2025
- Completion date
- Jun 10, 2025
- First posted
- Dec 8, 2025
- Last posted
- Dec 8, 2025
- Enrollment
- 17
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Stanford UniversityLead sponsor
- Stanford UniversityOfficial
- Stanford UniversitySponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.